Glaxosmithkline Pharmaceuticals Ltd

  • BSE Code : 500660
  • NSE Symbol : GLAXO
  • ISIN : INE159A01016
  • Industry :PHARMACEUTICALS - MULTINATIONAL

up-arrow 2,515.10 17.10(0.68%)

Open Price (₹)

2,498.00

Prev. Close (₹)

2,498.00

Volume (No’s)

41,285

Market Cap (₹)

42,607.31

Low Price (₹)

2,495.00

High Price (₹)

2,540.00

 

Board Meetings

Start Date End Date Purpose
13-Oct-2026 03-Nov-2026 Glaxosmithkline Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 inter alia to consider and approve As per attachment
21-Jul-2026 03-Aug-2026 Glaxosmithkline Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/08/2026 ,inter alia, to consider and approve approve and take on record the Un-audited financial results for the first quarter ended 30th June 2026. Outcome of Meeting (As per BSE Announcement dated on: 03.07.2026)
22-Apr-2026 13-May-2026 Glaxosmithkline Pharmaceuticals Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2026 inter alia to consider and approve Audited Financial Results (Standalone & Consolidated) for the year ended 31st March 2026 and dividend if any Outcome of Meeting (As per BSE Announcement dated on: 13.05.2026)
02-Mar-2026 02-Mar-2026 Outcome Of Board Meeting
06-Jan-2026 09-Feb-2026 Glaxosmithkline Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2026 inter alia to consider and approve take on record the Un-audited financial results for the third quarter & nine months ended 31st December 2025. Outcome of Meeting (As Per BSE Announcement Dated on: 09/02/2026)

Copyright © 2026 Arihant Capital Markets Ltd. All rights Reserved.

Designed, Developed and Content powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

x
  • QR-CodeNew